ストックスクリーナーアプリを入手
31.69
6.44%
-2.18
アフターアワーズ：
31.71
0.02
+0.06%
前日終値:
$33.87
開ける：
$34.31
24時間の取引高:
24.78M
Relative Volume:
1.15
時価総額：
$7.21B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
45.93
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
-5.15%
1か月 パフォーマンス:
-20.42%
6か月 パフォーマンス:
-38.15%
1年 パフォーマンス:
+23.16%
1日の値動き範囲:
$31.66
$34.35
1週間の範囲:
$31.66
$36.45
52週間の値動き範囲:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
31.69 | 7.71B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
After a 36% Rally in 2025, Is HIMS Stock Still a Good Buy Right Now? - TIKR.com
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Target Cut - Quiver Quantitative
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears - TechStock²
Hims & Hers health authorizes $250 million share repurchase program - MSN
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill - TechStock²
Hims & Hers Health: Capitalizing On Healthcare Innovation (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock: A Pivotal Year of Investment and Uncertainty - AD HOC NEWS
Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill - Investing.com Canada
Amazon Pharmacy to offer Wegovy pill for as little as $25 a month (AMZN:NASDAQ) - Seeking Alpha
Hims & Hers CEO Bets On Personalized Healthcare And AI In 2026 — Wall Street Braces For A Costly Year - Stocktwits
Hims & Hers Growth Story Has A Lot To Prove In 2026 (NYSE:HIMS) - Seeking Alpha
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? - The Globe and Mail
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth (NYSE:HIMS) - Seeking Alpha
2026: The Year of the Consumer in Healthcare - Hims & Hers Newsroom
HIMS Stock Falls after BofA Slashes Price Target to a Street-Low of $29 - TipRanks
BofA Securities lowers Hims and Hers stock price target on 2026 investment concerns By Investing.com - Investing.com UK
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List - Stocktwits
Hims & Hers enters 2026 on solid ground — stock rises even after Novo Nordisk leaves it off Wegovy partner list - MSN
Hims & Hers Health: Under-Appreciated Upside (NYSE:HIMS) - Seeking Alpha
Hims & Hers: A Rare GARP Setup After The Market Reset (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Capitalizing On Robust Subscriber/ARPU GrowthUpgraded Buy Rating (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Defies Analyst Concerns with Strategic Pivot - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts - Yahoo Finance
Hims & Hers Health: Could Start To Look Interesting In 2026 (NYSE:HIMS) - Seeking Alpha
3 Stocks That May Be Trading Below Their Estimated Value - simplywall.st
Hims & Hers Health Is Building A Hormonal Empire (NYSE:HIMS) - Seeking Alpha
How strong is Hims Hers Health Inc stock revenue growthJuly 2025 Review & Stock Market Timing Techniques - moha.gov.vn
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization - Yahoo Finance
Hims & Hers: A Great Moment To Buy The Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc. Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Promising Healthcare Stocks To Keep An Eye OnJanuary 4th - MarketBeat
Healthcare Stocks To ConsiderJanuary 1st - MarketBeat
Promising Healthcare Stocks To ConsiderJanuary 3rd - MarketBeat
Hims & Hers Health (NYSE:HIMS) Seems To Use Debt Rather Sparingly - simplywall.st
Best Healthcare Stocks To Watch NowJanuary 2nd - MarketBeat
The Biomarker Blood Testing Gold Rush Is Here - Athletech News
HIMS Stock On A Losing Spree: Here's Why - Forbes
Market Sentiment Sours for Hims & Hers Shares - AD HOC NEWS
Mixed options sentiment in Hims and Hers Health with shares down 2.47% - Yahoo Finance
HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns - Trefis
How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing - Stock Traders Daily
Best Healthcare Stocks Worth WatchingDecember 28th - MarketBeat
Healthcare Stocks To Watch TodayDecember 31st - MarketBeat
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus - ts2.tech
Hims & Hers Faces Investor Scrutiny Amid Profitability Concerns - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Notable Tuesday Option Activity: Z, UPS, HIMS - Nasdaq
Best Healthcare Stocks To Watch TodayDecember 30th - MarketBeat
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - Yahoo Finance
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
1.55%
大文字化:
|
ボリューム (24 時間):